Global Equine Healthcare Market: Snapshot

Equine healthcare products are the drugs, vaccines and supplemental feed additives used for the therapeutics purposes for the equine (horses, foals, mares etc.) species. The global equine healthcare market is driven by the undying trend of horse-racing, high incidence of equine infections, and global animal health development management programs. The market is likely to face a challenge from the decreasing population of equine species in worldwide. Rising demand for pet insurance will open up new avenues for the global equine healthcare market to grow in the near future.

According to the report, the global equine healthcare market is likely to expand at a CAGR of 4.2% from 2017 to 2025, rising to an estimated valuation of US$862.7 mn in 2025.

global equine healthcare market

Inactivated Vaccines to Remain Most Lucrative Vaccine Type in Equine Healthcare Market

Based on product type, the equine healthcare market has been segmented into drugs, vaccines and supplemental feed additives. The drugs segment is anticipated to hold the largest share in 2016, followed by vaccines and supplemental feed additives, owing to high market requirements of drugs for the treatments of equines. By drugs type, the anti-infectives sub-segment is expected to hold the largest share in 2016, followed by anti-inflammatory, parasiticides and others sub-segments, owing to high incidence of infections among equines and strong efficacy of anti-infective drugs to cure the infectious diseases occurring in equines.

In terms of vaccines type, the inactivated sub-segment is anticipated to hold the largest share in 2016, followed by live attenuated, recombinant and others sub-segments, as inactivated vaccines are considered as the safest and show strong efficacy over types of vaccines. By supplemental feed additives type, the minerals and vitamins sub-segments are estimated to hold significant shares in 2016 followed by proteins and amino acids, enzymes and others, due to the high requirements of minerals and vitamins as nutritional supplements for equines.

Asia Pacific to Present Highly Promising Growth Opportunities as Racing Sports Gain Popularity

Geographically, the global equine healthcare market is divided into North America, Europe, Asia Pacific, Latin America and Middle East & Africa regions. The North America and Europe equine healthcare markets are expected to grow during the forecast period due to the significant adoption rate of equines per households, high interest in equine care, impressive animal healthcare expenditure, and strong business operation of the brand companies in these two regions.

The Asia Pacific equine healthcare market is expected to hold the third largest share in 2016 but anticipated to increase with the highest rate during the forecast period due to the emerging trend of equine care, rising focus on animal healthcare, increased expenditure on healthcare products for animals, and the increased popularity of racing sports. High incidence rate of equine infections such as Potomac horse fever, Venezuelan equine encephalomyelitis is the primary reason to navigate the Latin America equine healthcare market during the forecast period. The Middle East and Africa equine healthcare market is the least contributor in the global equine healthcare market due to less population of horses in Middle East region and nominal animal healthcare expenditure in the region.

Some of the most prominent players in the global equine healthcare market are Bayer AG (Bayer Animal Health), Boehringer Ingelheim, Ceva Santé Animale, Sanofi (Merial), Eli Lilly and Company (Elanco), Equine Products UK Ltd, Merck & Co. (Merck Animal Health), Purina Animal Nutrition LLC., Vetoquinol S.A., and Zoetis.

Global Equine Healthcare Market: Overview

This report provides in-depth region wise and country wise analysis of the equine healthcare market. Stakeholders of this report include manufacturers of veterinary products, industry practitioners, research professionals, and new players planning to enter the market.

The report provides qualitative and quantitative analysis of the global equine healthcare market. Qualitative analysis comprises market dynamics, trends, product overview, and country-level market information. Quantitative analysis includes market share held by companies, market size, and forecast for the global equine healthcare market in major countries. Market revenue is provided in terms of US$ Mn from 2015 to 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 for all the segments, considering 2016 as the base year. The executive summary of the report provides a snapshot of the equine healthcare market with information on leading segments and sub-segments, country wise market information with respect to the market size, growth rate (CAGR %), and growth factors.

The market overview section comprises impact factors such as drivers, restraints, and opportunities for the global equine healthcare market. These factors would aid the stakeholders in establishing a strong foothold in the global equine healthcare market. Furthermore, the market overview section comprises key industry events, product overview, market attractiveness analysis and emerging trend in the equine healthcare products. The market attractiveness analysis provides a graphical view comparing the growth and market dynamics in various segments and country wise to identify the most attractive market.

Global Equine Healthcare Market: Segmentation

The equine healthcare market has been extensively analyzed on basis of the product type (drugs, vaccines and supplemental feed additives), disease type and distribution channel, and geography. The market by product type is further segmented as drugs, vaccines and supplemental feed additives. The drugs sub-segment is classified into anti-infectives, anti-inflmmatory, paracititidis and others whereas the vaccines sub-segment is categorized into inactivated, live attenuated, recombinant and others. Additionally, the supplemental feed additives type sub-segment is segmented into minerals, vitamins, proteins and amino acids, enzyme, others. The distribution channel segment has been classified into veterinary hospitals and clinics, retail pharmacies and drug stores and others. Furthermore, the market by disease type is classified into west nile virus, equine rabies, potomac horse fever, tetanus, equine influenza, equine herpes virus, equine encephalomyelitis, others.

 By geography, the equine healthcare market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Moreover, analysis for the major countries comprising U.S. Canada, Germany, U.K., France, Spain, Italy, Japan, China, India, Australia and New Zealand, Brazil, Mexico, GCC (Gulf Cooperation Council) and South Africa have also been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the equine healthcare market in various regions have been provided in this section. This report also includes various ups and downs about particular country or geography that has impacted the overall market globally.

Global Equine Healthcare Market: Competitive Dynamics

The report provides a detailed outline/blueprint of the equine healthcare market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market. The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. Prominent key players are Bayer AG (Bayer Animal Health), Boehringer Ingelheim, Ceva Santé Animale , Eli Lilly and Company (Elanco) , EQUINE PRODUCTS UK LTD , Merck & Co. (Merck Animal Health), Sanofi (Merial), Purina Animal Nutrition LLC., Vetoquinol S.A. and Zoetis.

The global equine healthcare market is segmented as given below:

Global Equine Healthcare Market, by Product Type

  • Drugs
    • Anti-infectives
    • Anti-inflammatory
    • Parasiticides
    • Others
  • Vaccine
    • Inactivated
    • Live Attenuated
    • Recombinant
    • Others
  • Supplemental Feed additives
    • Proteins and amino acids
    • Vitamins
    • Enzymes
    • Minerals
    • Others

Global Equine Healthcare Market, by Disease Type

  • Equine Influenza
  • Equine Herpes virus
  • Equine Encephalomyelitis
  • West Nile Virus
  • Equine Rabies
  • Potomac Horse Fever
  • Tetanus
  • Others

Global Equine Healthcare Market, by Distribution Channel

  • Veterinary Hospitals and Clinics
  • Retail Pharmacies and Drug Stores
  • Others

Global Equine Healthcare Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa
.